Grant of Restricted Stock Units and Warrants to Employees in Genmab

Summary by AI BETAClose X

Genmab granted 4,993 restricted stock units (RSUs) and 4,607 warrants; RSU fair value equals closing price DKK 3,496 each (total DKK 17,455,528), warrants have exercise price DKK 3,496 and Black-Scholes fair value DKK 1,230.13 each (total DKK 5,667,209); combined potential issuance of 9,600 shares, potential cash proceeds on full exercise DKK 16,106,072, and aggregate grant fair value DKK 23,122,737, with RSUs and warrants vesting after 3 years and warrants expiring seven years post-grant, representing a standard employee-compensation grant with modest dilution and multi-year expense recognition.

Disclaimer*

UK 100

Latest directors dealings